menu search

Jpmorgan ceo jamie dimon arrives at capitol hill to meet with house democrats

CNBC's Eamon Javers and JPMorgan's Jamie Dimon on 'Halftime Report' to discuss meeting with democrats on Capitol Hill, Dimon's presidential ...

June 6, 2023, 1:37 pm

Bellerophon (blph) down 87% as lung disease candidate fails

Bellerophon's (BLPH) shares fall as a late-stage study of INOpulse to treat fibrotic interstitial lung disease fails to meet its primary endpoint....

June 6, 2023, 1:15 pm

U.s. wide-moat stocks on sale - the june 2023 heat map

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in ...

June 6, 2023, 12:25 pm

Why is t2 biosystems (ttoo) stock up 17% today?

T2 Biosystems (NASDAQ: TTOO ) stock is rising higher on Tuesday after the company revealed its submission for a Breakthrough Device Designation for it...

June 6, 2023, 8:28 am

Robert f. kennedy jr. silent on bitcoin and cbdc during twitter talk with elon musk

Tesla CEO and Twitter owner Elon Musk hosted a conversation with presidential candidate Robert F. Kenne...

June 6, 2023, 12:59 am

Vizsla silver: a strong candidate for expected bull market

Vizsla Silver Corp. is a good candidate to profit from the next bull market in precious metals as the e...

June 6, 2023, 12:34 am

2 tech stocks to buy for strong eps growth

Cloud computing provider ServiceNow (NOW) and internet infrastructure services provider Verisign (VRSN) are two worthy ...

June 6, 2023, 12:28 am

In one chart: as mike pence, chris christie and doug burgum enter the race, here are the republicans running for president in 2024

This is MarketWatch’s list of the 2024 Republican presidential contenders and the status of their candid...

June 5, 2023, 7:03 pm

Why shares of day one pharmaceuticals are up monday

Day One has begun a rolling NDA for its candidate DAY101 as a monotherapy for relapsed or progressive p...

June 5, 2023, 12:30 pm

Pro-bitcoin candidate robert kennedy jr. ‘can and will’ beat trump, desantis: jack dorsey

Block co-founder and CEO Jack Dorsey has backed Bitcoin advocate Robert F. Kennedy Jr. for his 2024 presidential run. Read Full Story The post Pro-Bit...

June 5, 2023, 9:59 am

Stock split watch: is costco next?

With a share price of around $500, Costco is a good candidate for a stock split. Costco has had three s...

June 4, 2023, 9:14 am

Up 48% in 2023, is this biotech stock a buy?

Krystal Biotech recently reached an important milestone with the approval of its lead candidate Vyjuvek...

June 3, 2023, 8:30 am

Lava (lvtx) up on j&j's (jnj) cancer study candidate selection

LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical stu...

June 2, 2023, 12:09 pm

Aclaris therapeutics to participate in two june healthcare investor conferences

WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...

June 2, 2023, 11:00 am

Biontech says drug from oncoc4 partnership shows promise in mid-stage trial

BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partn...

June 2, 2023, 6:48 am

Ishares msci indonesia etf: low valuation and economic restructuring

Indonesia is the second candidate, after India, for the title of Asia's best emerging economy. Buying a...

June 2, 2023, 4:58 am

Netapp is gearing up to breakout after earnings top estimates

NetApp, Inc. NASDAQ: NTAP reported earnings for their fourth quarter ending April 2023 yesterday after the close and topped consensus estimates. While...

June 1, 2023, 8:31 am

Pyxis (pyxs) up on advancing cancer therapy candidates

Pyxis' (PYXS) shares rise as the company advances its phase I candidates, PYX-106 and PYX-201, for chal...

May 31, 2023, 10:45 am

Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...

May 31, 2023, 3:00 am

Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...

May 31, 2023, 3:00 am


Search within

Pages Search Results: